Ninety-nine percent of all “essential” hypertension can be controlled by using the NoLoCo strategy, without causing any significant side-effects and without an increase in insulin resistance. NoLoCo stands for Norvasc (amlodipine), Lozol (indapamide), and Cozaar (losartan), but the medicines are considered and used in reverse order.
Mihelic, F. Matthew MD, "The NoLoCo Strategy for Essential Hypertension" (2023). Faculty Publications. 21.